2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$5.22-$0.09 (-1.79%)
Price as of Aug 03, 2026 11:32 AM EDT- $557.5MMarket Cap
- 799.39%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$5.22-$0.09 (-1.79%)
RLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.31 | ||
Change | -$0.04 (-0.75%) | ||
Open | $5.38 | ||
High | $5.40 | ||
Low | $5.00 | ||
Previous Close | $5.35 | ||
Volume | 1,717,951 | ||
30-Day Average Volume | 1,675,916 | ||
1-Week Change | 2.51% | ||
1-Month Change | -23.27% | ||
1-Year Change | 799.39% | ||
3-Year Change | 102.67% | ||
5-Year Change | -79.58% | ||
Fundamentals | |||
Shares Outstanding | 105.0M | ||
Total Assets | $235.4M | ||
Market Cap | $557.5M | ||
Enterprise Value | $547.7M | ||
Period: QTR TTM FY | |||
Revenue | -$549,964.00 | ||
Net Income | -$19.1M | ||
Free Cash Flow | -$15.1M | ||
EBIT | -$19.1M | ||
EBITDA | -$19.1M | ||
Net Working Capital | $222.5M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | -29 | ||
Enterprise Value/Revenue | -996 | ||
P/B | 3 | ||
P/E | -24 | ||
PEG | -1 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 09/30/2019 | ||
Earnings & Revenue